Clinical Trial Update: Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma [Phase 3]

View source ↗

Summary

This Phase 3 study evaluated the safety and efficacy of House Dust Mite Allergoid in treating bronchial asthma and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchial Asthma

Drugs mentioned

• House Dust Mite Allergoid (house dust mite allergoid extract)

Snippet

Sponsor: Allergopharma GmbH & Co. KG | Conditions: Respiratory Hypersensitivity | Phase 3 | Status: COMPLETED